Dataset Information


Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients.

ABSTRACT: BACKGROUND:Severe and fulminant Clostridioides difficile infection is associated with high mortality rates. While faecal microbiota transplant has been shown to be effective for recurrent C difficile infection, there is little data on the utility of faecal microbiota transplant in severe or fulminant C difficile infection. AIM:To compare the outcomes of antibiotics and faecal microbiota transplantation vs antibiotics alone (standard of care) in critically ill patients with severe or fulminant C difficile infection. METHODS:This was a retrospective, matched cohort study in one urban tertiary academic care centre including 48 patients hospitalised with severe or fulminant C difficile infection who required care in intensive care unit. RESULTS:Patients who received faecal microbiota transplantation (n = 16) had a 77% decrease in odds for mortality (OR 0.23, 95% CI 0.06-0.97) with a number needed to treat of 3 to prevent one death. CONCLUSIONS:Faecal microbiota transplantation provides mortality benefit over standard of care for severe and fulminant C difficile infection and should be considered in critically ill patients.


PROVIDER: S-EPMC6817391 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC6680358 | BioStudies
2018-01-01 | S-EPMC6114236 | BioStudies
2017-01-01 | S-EPMC6075516 | BioStudies
2016-01-01 | S-EPMC4911291 | BioStudies
2014-01-01 | S-EPMC4068257 | BioStudies
2014-01-01 | S-EPMC4265774 | BioStudies
2015-01-01 | S-EPMC4532993 | BioStudies
2020-01-01 | S-EPMC7186269 | BioStudies
2016-01-01 | S-EPMC5453186 | BioStudies
1000-01-01 | S-EPMC4817604 | BioStudies